Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity

par Papadas, Athanasios, Arauz, Garrett, Cicala, Alexander, Wiesner, Joshua, Asimakopoulos, Fotis
Publié dans J Histochem Cytochem (2020)

Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers

par Mushtaq, Muhammad Umair, Papadas, Athanasios, Pagenkopf, Adam, Flietner, Evan, Morrow, Zachary, Chaudhary, Sibgha Gull, Asimakopoulos, Fotis
Publié dans J Immunother Cancer (2018)

VERSICAN PROTEOLYSIS PREDICTS IMMUNE EFFECTOR INFILTRATION AND POST-TRANSPLANT SURVIVAL IN MYELOMA

par Dhakal, Binod, Pagenkopf, Adam, Mushtaq, Muhammad Umair, Cunningham, Ashley M, Flietner, Evan, Morrow, Zachary, Papadas, Athanasios, Hope, Chelsea, Leith, Catherine, Hematti, Peiman, Hari, Parameswaran, Callander, Natalie S, Asimakopoulos, Fotis
Publié dans Leuk Lymphoma (2019)

Versican-derived matrikines regulate Batf3-dendritic cell differentiation and promote T-cell infiltration in colorectal cancer

par Hope, Chelsea, Emmerich, Philip B., Papadas, Athanasios, Pagenkopf, Adam, Matkowskyj, Kristina A., Van De Hey, Dana R., Payne, Susan N., Clipson, Linda, Callander, Natalie S., Hematti, Peiman, Miyamoto, Shigeki, Johnson, Michael G., Deming, Dustin A., Asimakopoulos, Fotis
Publié dans J Immunol (2017)

Expression of Nras(Q61R) and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice

par Wen, Zhi, Rajagopalan, Adhithi, Flietner, Evan D., Yun, Grant, Chesi, Marta, Furumo, Quinlan, Burns, Robert T., Papadas, Athanasios, Ranheim, Erik A., Pagenkopf, Adam C., Morrow, Zachary T., Finn, Remington, Zhou, Yun, Li, Shuyi, You, Xiaona, Jensen, Jeffrey, Yu, Mei, Cicala, Alexander, Menting, James, Mitsiades, Constantine S., Callander, Natalie S., Bergsagel, P. Leif, Wang, Demin, Asimakopoulos, Fotis, Zhang, Jing
Publié dans Blood (2021)